Suppr超能文献

[腿部静脉造影中的全身和局部反应,特别提及含碘造影剂。使用不同渗透压和碘浓度的含碘造影剂进行的随机、前瞻性、个体内双盲研究。I]

[Systemic and local reactions in leg phlebography with special reference to iodine-containing contrast media. Randomized, prospective, intraindividual double-blind study using iodine-containing contrast media of different osmolarity and iodine concentration. I].

作者信息

Hagen B

出版信息

Radiologe. 1984 Jan;24(1):46-50.

PMID:6709879
Abstract

Iopamidol, a non-ionic, tri-iodinated radiographic contrast medium, was superior to the ionic substances ioxaglate, ioglicinate and ioxitalamate in the ascending phlebography. In 180 examinations on 90 patients (report I), which were carried out intraindividually by double blind technique, distinct differences were recorded in particular at pain registration. Since iopamidol was well tolerated in nearly all cases, pain was registered in 10% in ioxaglate, in 22% in ioglicinate and in 37% in ioxitalamate. Anaphylactoid reactions had been observed in one case (1.1%) with iopamidol, in 7% with ioglicinate, in 10% with ioxitalamate and in 17% with ioxaglate. The low incidence of clinically manifest postphlebographic thrombophlebitis and deep venous thrombosis was surprising. In no case was deep venous thrombosis seen after the application of low-osmolar substances, whereas transitory superficial vein irritations could be observed more frequently (10% in iopamidol and 21% in ioxaglate). In ioglicinate as well as in ioxitalamate one deep vein thrombosis and in 10% resp. 30% superficial thrombophlebitis were recorded.

摘要

碘帕醇是一种非离子型三碘造影剂,在静脉造影中,它优于离子型造影剂碘克沙酸、碘甘酸和碘他拉酸。在对90例患者进行的180次检查(报告I)中,采用双盲技术进行个体内对照,特别在疼痛记录方面发现了明显差异。由于几乎在所有情况下碘帕醇的耐受性都良好,碘克沙酸组疼痛发生率为10%,碘甘酸组为22%,碘他拉酸组为37%。观察到碘帕醇组有1例(1.1%)发生类过敏反应,碘甘酸组为7%,碘他拉酸组为10%,碘克沙酸组为17%。静脉造影后临床表现为血栓性静脉炎和深静脉血栓形成的发生率较低,这令人惊讶。应用低渗造影剂后未发现深静脉血栓形成,而短暂性浅静脉刺激则更常见(碘帕醇组为10%,碘克沙酸组为21%)。碘甘酸组和碘他拉酸组分别记录到1例深静脉血栓形成,浅静脉血栓形成发生率分别为10%和30%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验